Mangalam Drugs and Organics Share Price
11 Sep, 2026 11:05 AM (IST)
Mangalam Drugs and Organics Performance
- Today's Low
- ₹33
- Today's High
- ₹37
- 52 Week Low
- ₹23
- 52 Week High
- ₹80
- Open Price₹35
- Previous Close₹35
- Volume148,765
- 50 DMA₹29.30
- 100 DMA₹30.10
- 200 DMA₹36.70
Mangalam Drugs and Organics Chart
Investment Returns
- Over 1 Month + 33.61%
- Over 3 Month + 28.8%
- Over 6 Month + 9.76%
- Over 1 Year -52.61%
Smart Investing Starts Here Start SIP with Mangalam Drugs and Organics for Steady Growth!
Mangalam Drugs and Organics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -1.5
- PEG Ratio
- 0
- Market Cap Cr
- 58
- P/B Ratio
- 0.6
- Average True Range
- 2
- EPS
- -24.2
- Dividend Yield
- 0
- MACD Signal
- 1
- RSI
- 71.84
- MFI
- 80.94
Latest Stock News Updates
Newspaper publication regarding Notice of 53rd Annual General Meeting to be held on 23rd September, 2026 and information on E-voting.
- BSE India
- 1 week 2 days ago
Intimation of dispatch of Annual Report for 53rd Annual General Meeting for the financial year 2025-26 to be held on Wednesday, September 23rd, 2026 to the Shareholders of the Company.
- BSE India
- 1 week 3 days ago
Annual Report of the Company, Notice convening 53rd Annual General Meeting for the financial year 2025-26 to be Held on Wednesday, September 23rd, 2026 and Intimation of Cut-off Date for remote E-voting of the Company.
- BSE India
- 1 week 3 days ago
Mangalam Drugs and Organics Financials
Mangalam Drugs and Organics Technicals
EMA & SMA
- Bearish Moving Average 1
- Bullish Moving Average 15
- 20 Day
- ₹30.30
- 50 Day
- ₹29.30
- 100 Day
- ₹30.10
- 200 Day
- ₹36.70
Resistance and Support
- R3 39.10
- R2 37.00
- R1 35.90
- S1 32.80
- S2 30.70
- S3 29.60
Mangalam Drugs and Organics Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-12 | Quarterly Results | |
| 2026-05-14 | Audited Results | |
| 2026-03-26 | Others | Inter-alia, to consider 1. Taking note of Resignation of Ms. Anuradha Pandey as Company Secretary & Compliance Officer. 2. Appointment of Ms. Shweta Patel as Company Secretary & Compliance Officer. |
| 2026-02-06 | Others | |
| 2026-01-15 | Quarterly Results |
About Mangalam Drugs and Organics
Mangalam Drugs and Organics in the manufacture and sale of Active Pharmaceutical Ingredients (API) for various therapeutic segments viz. Anti-Malaria, Anti-Retrovirat, Anti-Hypertensive etc. It is the only API company globally to qualify under the Bill Clinton Foundation for supply of Anti-Malarial drugs and is amongst the 8 players globally (6 Formulators and 2 API players) with WHO prequalification for Anti-Malaria APIs- Artemether and Lumefantrine. View More- NSE Symbol
- MANGALAM
- BSE Symbol
- 532637
- ISIN
- INE584F01014
Similar Stocks to Mangalam Drugs and Organics
Popular Stocks
Mangalam Drugs and Organics FAQs
Mangalam Drugs and Organics share price is ₹36 As on 11 September, 2026 | 10:51
The Market Cap of Mangalam Drugs and Organics is ₹57.7 Cr As on 11 September, 2026 | 10:51
The P/E ratio of Mangalam Drugs and Organics is -1.5 As on 11 September, 2026 | 10:51
The PB ratio of Mangalam Drugs and Organics is 0.6 As on 11 September, 2026 | 10:51
The 52 week High & Low of Mangalam Drugs and Organics is ₹79.5/₹22.8 respectively As on 11 September, 2026 | 10:51
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.